BioCentury
ARTICLE | Financial News

ContraVir completes follow-on

April 27, 2017 9:12 PM UTC

Infectious disease company ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) raised $12 million on April 25 through the sale of 12 million shares at $1 in a follow-on underwritten by Canaccord Genuity and ...

BCIQ Company Profiles

Hepion Pharmaceuticals Inc.